High Quality Phamaceutical Grade Rivaroxaban Intermediate CAS 366789-02-8

Product Details
Customization: Available
Product Name: Rivaroxaban
CAS: 366789-02-8
Still deciding? Get samples of US$ 250/kg
Request Sample
Gold Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
R&D Capabilities
The supplier has 3 R&D engineers, you can check the Audit Report for more information
Product Certification
The supplier's products already have relevant certification qualifications, including:
CE
to see all verified strength labels (15)
  • High Quality Phamaceutical Grade Rivaroxaban Intermediate CAS 366789-02-8
  • High Quality Phamaceutical Grade Rivaroxaban Intermediate CAS 366789-02-8
  • High Quality Phamaceutical Grade Rivaroxaban Intermediate CAS 366789-02-8
  • High Quality Phamaceutical Grade Rivaroxaban Intermediate CAS 366789-02-8
  • High Quality Phamaceutical Grade Rivaroxaban Intermediate CAS 366789-02-8
  • High Quality Phamaceutical Grade Rivaroxaban Intermediate CAS 366789-02-8
Find Similar Products

Basic Info.

Model NO.
HMJ
MOQ
1kg
Form
Powder
Delivery
Express 5-7 Days Arrive
Grade
Phamaceutical Grade
Package
1kg Per Foil Bag, 10 Bags Per Carton. 25 Kg Per Dr
Transport Package
Foil Bag/Drum
Specification
99%
Trademark
HMJ
Origin
China
Production Capacity
100 Tons /Month

Product Description

Product Description

            High Quality Phamaceutical Grade Rivaroxaban Intermediate CAS 366789-02-8

High Quality Phamaceutical Grade Rivaroxaban Intermediate CAS 366789-02-8

Rivaroxaban is an oral anticoagulant. It is an orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects lasts 8 to 12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
There is currently no specific way to reverse the anticoagulant effect of rivaroxaban in the event of a major bleeding event, unlike w-arfarin.


Application:

Rivaroxaban can be used to prevent strokes in those with atrial fibrillation due to causes other than heart valvedisease, and at least one additional risk factor for stroke (congestive heart failure, hypertension, age, diabetes, and prior stroke)

Rivaroxaban can also be used to prevent the formation of blood clots in the veins (deep venous thrombosis) in adults who have had an operation to replace a hip or knee and for treatment and prevention of acute deep venous thrombosis in adults. It can not be used for prevention of venous thrombosis in hospitalized medically ill patients.

High Quality Phamaceutical Grade Rivaroxaban Intermediate CAS 366789-02-8
High Quality Phamaceutical Grade Rivaroxaban Intermediate CAS 366789-02-8

High Quality Phamaceutical Grade Rivaroxaban Intermediate CAS 366789-02-8High Quality Phamaceutical Grade Rivaroxaban Intermediate CAS 366789-02-8High Quality Phamaceutical Grade Rivaroxaban Intermediate CAS 366789-02-8High Quality Phamaceutical Grade Rivaroxaban Intermediate CAS 366789-02-8High Quality Phamaceutical Grade Rivaroxaban Intermediate CAS 366789-02-8High Quality Phamaceutical Grade Rivaroxaban Intermediate CAS 366789-02-8

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier